![Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show](https://d3dthqtvwic6y7.cloudfront.net/podcast-covers/000/037/269/small/pharmaceuticals-biotechnology-pharma-biotech-resources.jpg)
Summary: In this Pharma IQ interview Kristof Vercruysse, Director Clinical Operations at Ablynx, speaks to Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, about innovation in phase I clinical development and optimisation of biomarker development strategies. Vercruysse discusses biomarker